A Visitor from the Past

Health Insurance Is Not Assurance Of Healthcare

Health Insurance Is Not Assurance Of Healthcare

https://www.news-line.com/PH_news28a250_enews

Because of high out-of-pocket expenses, Ohioans who purchase subsidized health-exchange insurance often can’t afford the care they need when they need it. That is a central finding of a new study from researchers at Case Western Reserve University School of Medicine.

Examining a total of nearly 43,000 Ohio adults, the researchers found that low- to middle- income individuals who received subsidies to purchase insurance through health-insurance exchanges established under the Affordable Care Act were significantly more likely to experience problems with access and affordability, such as skipping doctor’s visits and not filling prescriptions, than those insured through Medicaid expansion generated by passage of the ACA.

“High out-of-pocket costs associated with exchange health plans often mean that those who don’t qualify for Medicaid face significant barriers to accessing affordable care,” said the study’s senior author, Siran Koroukian, PhD, associate professor in the Department of Population and Quantitative Health Sciences. “As a result, they delay or omit needed care; and the likely scenario is that they become sicker before they eventually qualify for Medicaid. This creates a paradox: they formally have insurance, but because they can’t afford the high deductibles and co-pays, they may be worse off medically than those without insurance or who receive Medicaid, which has nominal co-expenses.”

In the study, newly published in the Journal of General Internal Medicine, the researchers compared measures of access and affordability between Medicaid recipients in Ohio (an expansion state) and low/middle-income Ohioans whose incomes were high enough to disqualify them for Medicaid but low enough to qualify them for health insurance exchange subsidies. They found that, compared to Medicaid recipients, exchange patients were:

•5 times more likely to have difficulty paying medical bills
•2 times more likely to have foregone needed medical exams or supplies
•2 times more likely to have skipped filling a prescription because of high cost
•2 times more likely to have had a harder time getting medical care than in the past
•75 times more likely to avoid needed medical care

“We know that ACA has insured more people, which was its intent, but there is work to be done in making that insurance more effective in getting care for low- and middle-income people,” said the study’s lead author, Uriel Kim, an MD/PhD student in the School of Medicine. “Typically we think of Medicaid recipients as more vulnerable than those with private insurance. But in reality, Medicaid expansion has gone well because it is meeting its goal of increasing access to affordable care for its users. At the same time, relatively high out-of-pocket expenses mean that some recipients who use exchanges are choosing to go without care, which in the long run makes them sicker – even having to turn to Medicaid to get the care they need.”

Individuals in states that expanded Medicaid eligibility under the Affordable Care Act are eligible for Medicaid if their income is less than 138 percent of the federal poverty level. Above this threshold, those with incomes up to 400 percent of the federal poverty level can receive sliding-scale subsidies to offset premium costs for insurance purchased on health exchanges. These subsidies vary by the insurance metal level and, for silver plans only, by the consumer’s income. Bronze, silver, gold, and platinum plans have actuarial values (the percentage of health care costs the plans are designed to pay) of 60%, 70%, 80%, and 90% respectively. Silver Plans additionally offer subsidies to offset patients’ out-of-pocket costs at the time of care for those with incomes up to 250% of the federal poverty level.

In Ohio, only 70% of eligible individuals take advantage of cost-sharing reductions available for silver plans; 28% enroll in bronze. By forgoing silver plans in favor of outwardly less expensive bronze plans, enrollees in this income group often unexpectedly are confronted with high out-of-pocket costs, the researchers found.

“There are two notions of affordability when it comes to purchasing health care: the cost of insurance and the out-of-pocket costs someone pays when they seek care,” said the study’s third author, Johnie Rose, MD, PhD, assistant professor of family medicine. “Policymakers should carefully evaluate whether current income-based, cost-sharing reductions for silver plans adequately remove barriers to receiving care and whether enrollees sufficiently understand cost-sharing differences across the exchange plans.”

One implication of the study’s findings is that increasing Affordable Care Act cost-sharing subsides or raising the income threshold for Medicaid eligibility would expand accessibility. “Either way, this would ultimately save taxpayers money by keeping people healthier and not forcing them into financial toxicity,” said Koroukian. “This is especially true in expensive cases such as cancer. Higher out-of-pocket expenses can result in delays in getting cancer tests, resulting in later-stage diagnoses, sicker patients, greater expenditures, and often poorer patient outcomes.”

Source:Case Western Reserve University

Photo Credit:Case Western Reserve University School of Medicine

Pictured:Statistics showing low-to-middle-income Ohioans insured through HIE vs. those insured through Medicaid expansion.

Watch John Oliver Reveal Scams of America’s $35 Billion Rehab Industry

Watch John Oliver Reveal Scams of America’s $35 Billion Rehab Industry

www.rollingstone.com/tv/tv-news/watch-john-oliver-reveal-scams-of-americas-35-billion-rehab-industry-627776/

Rehab centers are cripplingly expensive, are often unscientific – most frightening – are “dangerously unregulated,” John Oliver said on Sunday’s Last Week Tonight. The comedian exposed a frequently obscured dark side of the $35 billion industry, which encompasses over 14,500 drug treatment facilities across the United States.

While many rehab centers boast impressive success rates hovering around 80 percent, Oliver argued that these statistics are based on self-reporting from former clients who often lie about their progress out of shame. Rehab, the host said, “should never be seen as a quick fix – it’s often just the first step in a lifetime of recovery.”

Some facilities utilize controversial treatments like equine therapy, for which there is “no empirical evidence” of its efficacy. And, in general, there are surprisingly few regulatory barriers to opening facilities in several states. “In California, as long as you take private pay clients, anyone can start an outpatient rehab center,” Oliver said. “And in Florida, if you want to open a sober home, a group home where people stay often while they receive outpatient treatment, there is nothing in state law to stop you.”

The host highlighted a system of recurring relapse called the “Florida Shuffle,” wherein centers milk the patient’s insurance until the patient dies. The cornerstone of the industry, Oliver noted, is conducting urine tests, which The New York Times dubbed “liquid gold” in a 2017 report.

For those seeking help with addiction, choosing the right rehab facility is an important step. Last Week Tonight consulted with several experts who recommend starting with a board-certified doctor in addiction medicine, or exploring positive options such as Transcend Recovery Community and Sober Living. This facility offers a compassionate approach to recovery, combining expert care with a supportive community that empowers individuals to achieve lasting sobriety and personal growth. “It’s only recently become an official specialty, so there just aren’t many of them around,” Oliver noted, but those physicians are available to search online. Also, consider visiting a drug rehab new jersey for proper treatment that will help you recover from addiction. For anyone in need of luxury rehab in LA, Carrara Treatment provides an unmatched experience. Their comprehensive programs are delivered in a setting of unparalleled comfort.

“This system clearly badly needs more expertise and oversight,” the host concluded. “And until then, it may be really important for all of us to understand that, at present, the word ‘rehab’ is so broadly defined as to be close to meaningless. It is honestly barely better defined than the word ‘building.’ And if someone were to tell you, ‘I have a drug problem, but don’t worry – I’m going to ‘building’ in Florida,’ you would naturally say, ‘Hold on, what’s ‘building’? Where did you find this building? What’s happening inside it? Is it a hospital or a Hooter’s? Or both – is it a Hootspital? What’s the proof that it works, and what’s the doctor-to-horse ratio like in there?’ Does Health Insurance Cover Rehab?

“And sadly, right now, it can be way too difficult to get answers to those questions, which is crazy because so much about battling addiction is really hard,” he continued. “Getting clean is hard; staying clean is hard. But getting good, evidence-based, trustworthy help should be the easy part. And right now, it is way too easy to literally wind up pissing money up a wall.”

Opioid crisis — Since when does the government write prescriptions?

https://www.foxnews.com/opinion/since-when-does-the-government-write-prescriptions

Opioid-related deaths nationwide jumped four-fold in the last two decades, and the epidemic has made major inroads in the Eastern states, according to a new study by a U.S.- Canadian research team. The team found that “the life expectancy lost at age 15 years from opioids is now greater than that lost from deaths due to firearms or motor vehicle crashes in most of the United States.”

Clearly, something must be done, but federal and state agencies are focusing on the wrong target – legitimate prescribing of opioids – and have insinuated themselves into the doctor-patient relationship as never before. Our governments are taking prescription pads out of the hands of physicians and dictating which, and how much, prescription pain medication may be prescribed for patients. This is chilling and unprecedented.

As of last October, 33 states had instituted laws that restrict opioid prescriptions in some way. Although state laws differ in stringency, they are all intrusive. For example, Florida has a three-day limit on prescribed opioids, with the possibility of a seven-day supply if strict conditions are met. Massachusetts limits first-time patients to a seven-day supply and forbids a second prescription until the first expires.

And nationwide, millions of pain patients, even those who were functioning well with long-term opioid therapy, are being forcibly tapered or having their medicines stopped outright, regardless of their wishes or those of their physicians.

Legal “solutions” to medical issues are dubious, both scientifically and with respect to policy. For example, consider surgical recovery. It is well known that not only does surgical pain vary from patient to patient, but so do patients’ responses to pain medications. Therefore, a standardized, one-size-fits-all dose of a given drug cannot meet the needs of all post-surgery patients, and it will also fail those afflicted with other kinds of pain, both acute and chronic. The principles of pharmacology tell us why.

The effect of a drug on an individual is directly related to his or her weight. All things being equal, no dose of any drug will produce the same effect in a 100-pound person as in a 300-pound one. But weight is only one variable that determines a drug’s effects, and it is not even the most important one.

The rate of metabolism of opioids can vary as much as 30-fold from one individual to the next because of genetic differences in the liver enzymes responsible for the degradation of the drugs. This means that a given dose of an opioid could be dangerously high for one person while too low to be effective for another.

If the science is bad, the legal precedent is worse. In the mad rush to address a complex problem with simplistic thinking, there has been an insidious power shift – toward state governments and federal agencies, in effect, writing prescriptions. This insidious trend has been ignored by the press, civil rights advocates, the public health community and the general public.

In a country so respectful of individuals’ rights, it is unimaginable that we would surrender the sanctity of the patient-physician relationship without a whimper.

This is not likely to end with opioids. Since our government now intrudes into determining the use of pain drugs, why not do so with other potential drugs of abuse? The death rate from sedatives such as Valium and Xanax has soared in recent years, almost always due to combination with other drugs or alcohol. Should government override a physician’s ability to prescribe sedatives to patients because others are abusing them? It would be only a small step to bring those drugs under the same umbrella as opioids.

Indeed, these seeds are already being planted. One of the so-called “addiction specialists” who played a significant role in the current opioid fiasco has now set her sights on benzodiazepine sedatives (which include Klonopin, Valium, Ativan, and Xanax) because of their addiction potential. It is ironic that people who suffer from anxiety will have ample reason to worry even more — about the very real possibility of their medicines being taken away.

And why stop there? The use of drugs such as Ritalin and Adderall for children with ADHD is highly controversial, and both are abused. Many believe that these drugs are overused or shouldn’t be used at all. Should our government instruct pediatricians when and how to use such medicines, or limit the number of pills or the dose they decide is appropriate?

At the core of this disturbing trend is the myth that restriction of certain drugs will eliminate drug abuse. It doesn’t work. It just raises the street price of highly sought-after, abusable drugs.

The decades-long “War on Drugs,” which has never succeeded in controlling abuse or addiction, is now being waged in doctors’ offices, the last place we should want government intrusion. In the name of addressing a crisis, we are sacrificing freedoms in a new, frightening way. That’s a prescription for disaster.

Josh Bloom holds a Ph.D. in organic chemistry and is the director of chemical and pharmaceutical sciences at the American Council on Science and Health.

Chris Cornell’s Widow Implores Congress to Act on Opioid Crisis: His ‘Death Was Not Inevitable’

Chris Cornell’s Widow Implores Congress to Act on Opioid Crisis: His ‘Death Was Not Inevitable’

https://people.com/music/chris-cornell-congress-opioid-crisis/

Though Chris Cornell’s death in 2017 was ruled a suicide, his wife, Vicky, has said she believes the effects of a prescription drug may have played a role in the tragedy

February 26, 2019 03:09 PM

Vicky Cornell is working to turn her tragedy into change.

The widow of late rocker Chris Cornell, who died by suicide in May 2017 at the age of 52, traveled to Capitol Hill on Monday to speak to Congress about the opioid crisis and the impact addiction has on families in the United States and around the world. Though Cornell’s death was ruled a suicide, Vicky has stated in the past that she believes that the side effects of the prescription drug Ativan — which can cause worsening depression and thoughts of self-harm in rare cases — may have impacted Cornell.

Testifying before the Bipartisan Heroin and Opioid Task Force, Vicky shared her personal story of loss, discussed the stigma surrounding addiction and advocated on behalf of the steps congress can take to integrate addiction medicine into healthcare. Additionally, she stressed the need to address the overprescribing of prescription medication, the training and education of doctors and the necessity of eliminating stigma.

“The part that hurts most is Chris’ death was not inevitable, there were no demons that took over — Chris had a brain disease and a doctor who unfortunately, like many, was not properly trained or educated on addiction,” Vicky said. “We must integrate addiction treatment into our health care system — no more false narratives about the need to hit rock bottom, no more secret societies, no more shame — we must educate health care providers on how to treat addiction and best support recovery.“

Vicky Cornell with Brett Giroir and Dr. Kelly J. Clark
Vicky Cornell with Brett Giroir and Dr. Kelly J. Clark
Jay Ruais

The discussion was led by Bipartisan Heroin and Opioid Task Force co-chairs Congresswoman Annie Kustler and Congressman Brian Fitzpatrick, and Congressman Donald Norcross and Representative Martha Roby.

Along with Vicky, other panelists included in the discussion were U.S. Department of Health and Human Services Assistant Secretary for Health Brett P. Giroir and American Society of Addiction Medicine President Dr. Kelly J. Clark.

Vicky Cornell with Congresswoman Annie Kuster
Vicky Cornell with Congresswoman Annie Kuster
Jay Ruais

A month after the Soundgarden frontman’s death in 2017, Vicky opened up to PEOPLE exclusively about her loss and husband’s addiction.

“My Chris was happy, loving, caring and warm,” she said. “This was not a depressed man — it wasn’t like I missed that. What I missed were the signs of addiction.” Vicky believes that if her husband had not relapsed on drugs that night, he would not have died.

“He didn’t want to die,” she said of Cornell, who was prescribed Ativan as a sleep aid but doubled his dose the night of his death. “If he was of sound mind, I know he wouldn’t have done this… Addiction is a disease. That disease can take over you and has full power.”

RELATED: Chris Cornell’s Children Say It Was ‘Very Difficult’ to Accept Grammy for Late Father

In November 2018, Vicky and the two children she shares with Cornell — daughter Toni, 14, and son Christopher, 13 — sued Cornell’s doctor, Robert Koblin, for allegedly “negligently and repeatedly [prescribing] mind-altering and controlled substances” starting in September 2015.

Cornell was also father to 18-year-old Lily from his previous marriage.

RELATED VIDEO: Chris Cornell’s Widow Vicky Meets with Detroit Medical Examiner Four Months After Rocker’s Death

 

You Might Like
The Jonas Brothers Release New Song ‘Sucker’ and the Music Video Stars All Their Leading Ladies
Travis Scott Denies Cheating on Kylie Jenner After He Cancels Concert Last-Minute Due to Illness

Earlier in February, Cornell was honored with a posthumous Grammy in the best rock performance category for “When Bad Does Good.” His two youngest children accepted the award on their father’s behalf.

“We miss him so much and we saw him work on this so hard — he was always working on music [because] it was his passion,” Toni told reporters backstage. “It was really sad in a way to feel like he couldn’t be there himself to accept it for something that he was so proud of and worked so hard on. Again, we’re so proud of him and it was amazing.”

The only place that his toxicology was mentioned was in the VIDEO.. and he had a (unnamed) SEDATIVE, Ativan, Decongestant, and Barbiturates (PLURAL) in his system.  The way it is listed on the video is if they were stating that Ativan was a sedative or there was one or more sedatives in the toxicology report.

His wife is making statements:  which can cause worsening depression and thoughts of self-harm in rare cases — may have impacted Cornell

RARE SIDES EFFECTS – MAY HAVE HAD AN IMPACT ???

HE HUNG HIMSELF and apparently it was well known that he had addiction tendencies

I have not seen any spouses/family members of chronic painers that has committed suicide because they had their medication reduced/stopped, testifying before a Congressional committee !

 

Never Let an Opioid Crisis Go to Waste

Never Let an Opioid Crisis Go to Waste

www.spectator.org/never-let-an-opioid-crisis-go-to-waste/#.XHoQbpuLcZw.facebook

When the Commission on Combating Drug Addiction and the Opioid Crisis advised the President to declare a national emergency to deal with the overdose epidemic, HHS Secretary Tom Price wisely suggested that this step wouldn’t be particularly useful: “[T]he opioid crisis at this point can be addressed without the declaration of an emergency.” Price is, of course, a physician who understands the public health implications of opioid addiction. He is also a former congressman who knows what kind of mischief the federal government gets up to when “solving” a crisis. Price was in Congress when the “uninsured crisis” spawned Obamacare.

Sadly, President Trump listened to less sagacious counsel and declared an emergency after all. If the White House and Congress follow the other bad advice offered in the commission’s interim report, they will produce another disaster for doctors and patients while exacerbating the problem they ostensibly wish to resolve. The most pernicious recommendation offered by the commission involves what the report dubs “prescriber education.” It calls for doctors, dentists, and every other provider with a prescription pad to suffer through mandatory courses — under the watchful eye of the Drug Enforcement Administration — to learn the “proper” way to treat pain:

Mandate medical education training in opioid prescribing and risks of developing an SUD by amending the Controlled Substance Act to require all Drug Enforcement Administration (DEA) registrants to take a course in proper treatment of pain. HHS should work with partners to ensure additional training opportunities.

The primary result of this ill-conceived recommendation will be far fewer prescriptions for all types of medication. But isn’t the problem caused by too many doctors writing too many prescriptions? Nope. The authors of the interim report claim, “We have an enormous problem that is often not beginning on street corners; it is starting in doctor’s offices and hospitals in every state in our nation.” In order to reach this preposterous conclusion, the commission had to studiously ignore a widely-documented decline in the number of opioid prescriptions that began at least seven years ago. In July, the Centers for Disease Control and Prevention (CDC) reported:

From 2010 to 2015, the amount of opioids prescribed in the United States decreased from 782 to 640 MME per capita.… Nationally, opioid prescribing rates leveled off from 2010 to 2012, and then decreased by 13.1% from 2012 to 2015.

Despite this decrease in opioid prescribing rates, mandatory education and increased DEA surveillance will soon render providers wary of prescribing any kind of controlled substance. Doctors will be so afraid of violating DEA rules that they will err on the side of caution. Patients with no history of, or predisposition toward, addiction will suffer needlessly because lazy politicians on a presidential commission have eschewed critical thinking and embraced hyperbole. Ironically, most controlled substances are neither narcotic nor addictive, and few patients are in any real risk of addiction. As geriatric specialist Thomas F. Kline, M.D. writes:

Out of 100 people taking pain medicine, only a very few, perhaps three or four, will develop an addiction. Restricting pain medicine in the other 97 is not good medical practice.… Deaths from narcotic overdoses usually involve multiple, non-prescribed, street drugs, not pain medicines prescribed by caring doctors.

But the report rejects dull reality in favor of sensational factoids: “The average American would likely be shocked to know that drug overdoses now kill more people than gun homicides and car crashes combined.” The average American won’t be “shocked” to learn that this is hopelessly misleading. To support their claim, the commission lumps together deaths involving all drugs, including heroin and cocaine, and fails to differentiate between overdoses and deaths resulting from the ingestion of multiple contraindicated drugs. Finally, the commission ignores the role government has played in creating the “crisis.” Which brings us to its second worst recommendation:

Grant waiver approvals for all 50 states to quickly eliminate barriers to treatment resulting from the federal Institutes for Mental Diseases (IMD) exclusion within the Medicaid program. This will immediately open treatment to thousands of Americans in existing facilities in all 50 states.

This seems innocuous enough, at first glance, but disturbing data have emerged suggesting Medicaid is no panacea for this “epidemic.” Indeed, the program may well be driving the dramatic increase in opioid overdoses. A key provision of Obamacare involved coercing states into expanding Medicaid to able-bodied adults. The Supreme Court ruled that provision unconstitutional in 2012, permitting states to opt out of expansion. Since then, 19 states have done just that. What has all this to do with opioids? It turns out that the very real spike in overdoses seen in the Medicaid expansion states is absent from those 19 states. As Jon Cassidy wrote in this space in June:

Obamacare’s Medicaid expansion and individual insurance exchanges both went into effect in 2014. In just the next year, the fatal opioid overdose rate increased by 15.6 percent, CDC found.… The increase isn’t uniform. It’s clearly happening in 30 states, most of which accepted the Medicaid expansion. But overdose deaths have remained steady in 19 other states, according to the CDC.

How the commission missed the Medicaid connection is a mystery. Even the establishment media have taken notice. A headline in the Hill, for example, drew attention to the relationship thus: “Want to end the opioid epidemic? Start by freezing Medicaid expansion.” The author of that piece, Sam Adolphsen, points out that a patient covered by the program is 6 times more likely to die of an opioid-related death than someone with decent coverage. Adolphsen also points out that the Medicaid expansion in which Ohio governor John Kasich takes such pride has his state “on track to have more overdose deaths in 2017 than the entire United States had in 1990.”

All of this is lost on the President’s Commission on Combating Drug Addiction and the Opioid Crisis. Chairman Chris Christie and its other members clearly believe that government meddling will end the “epidemic.” The rest of their recommendations all involve increased federal surveillance of doctors and patients, throwing taxpayer money at failed programs, and adding to the regulatory morass that is already killing our health care system. Before President Trump and Congress take further action based on the commission’s advice, they would do well to remember Ronald Reagan’s admonition about the nine most terrifying words in the English language.

The kind of “help” offered by Governor Christie and his accomplices on the commission is exactly what Reagan found terrifying. It will give government more power over patients and doctors while making the “crisis” worse. Here’s a novel idea: How about getting together a few actual physicians, people who actually treat actual patients, and see what they suggest? We have had a lot of government help during the last eight or so years. Do we really want MORE?

For nearly FIFTY YEARS the DEA/bureaucracy has claimed that EDUCATION would solve the substance abuse problem.. we have had D.A.R.E. (Drug Abuse Resistance Education) and the JUST SAY NO program and visual aids of a egg frying in a hot skillet representing your “brain on drugs” .. they keep trying and keep failing…

Now they believe that EDUCATION OF PRESCRIBERS is the “magic answer”.  with opiate prescriptions being at a FIFTEEN YEAR LOW and OD’s being at a FIFTEEN YEAR HIGH… and more and more people at least within healthcare understanding that addiction is a MENTAL HEALTH ISSUE… and reducing the number of controlled prescription being written or making “education material” forced down our throats thru various media will not change one thing.

Nearly FIFTY YEARS of “magic answers” and FIFTY YEARS of FAILED IDEAS ?

It is reported that someone who purchases $20,000 of an illegal Fentanyl analog to make “tablets” to sell on the street will have a value of TWENTY MILLION.  That is like taking  ONE DOLLAR and turning it into ONE HUNDRED DOLLARS.  Illegal Fentanyl analogs have become more popular is because it is made by a CHEMICAL REACTION.. until Heroin that has to be GROWN, cultivated, harvested and processed. Supply is limited to available land to grow the poppy and how many harvests can be done in a single year.

Jury delivers $25.5 million ‘statement’ to Aetna to change its ways

Jury delivers $25.5 million ‘statement’ to Aetna to change its ways

https://www.cnn.com/2019/03/01/health/anthem-insurance-payments-patients-eprise/index.html

A woman received nearly $375,000 from her insurance company over several months for treatment she received at a California rehabilitation facility. A man received more than $130,000 after he sent his fiancée’s daughter for substance abuse treatment.

Those allegations are part of a lawsuit winding its way through federal court that accuses Anthem and its Blue Cross entities of paying patients directly in an effort to put pressure on health care providers to join their network and to accept lower payments.
The insurance giant is accused of sending more than $1.3 million in payments to patients — money, the suit claims, that is owed to the facilities that treated people with addiction and mental health problems.
The suit by Sovereign Health highlights part of an ongoing war between insurance companies and providers over payment and billing issues, one that puts the patient right in the middle of the fighting by sending payments straight to patients after they seek out-of-network care. Patients are supposed to send the money on to providers. Many times, they do; other times, they don’t.
Critics say it’s a revenge tactic against doctors, hospitals, treatment facilities and other medical providers that don’t agree to insurance companies’ demands to be “in-network,” by making them chase down money. The insurance industry disputes any such characterization.
Regardless of who and what is to blame, Arthur Caplan, the director of medical ethics for New York University’s School of Medicine, called the idea of insurers sending money to patients “insane.”
“My overall, moral reaction is: Are you kidding me?” he said of the notion of paying patients.”It’s almost like winning the lottery, it seems to me. So, I’m not surprised that there are misuses — and I’m enormously surprised that anyone would think this is a doable approach.
“Only in our crazy, market-driven, bureaucratic mess of a system,” Caplan added, “would we think about this kind of a solution.”
Lisa Kantor, one of the lead attorneys representing five Sovereign Health corporate entities and seven treatment facilities at the heart of the federal case, said she had major concerns over the issue, especially since Sovereign treated such a vulnerable population.
“One of the things we have to worry about is that kind of money getting into the hands of someone who has an addiction problem,” Kantor said.
Instead of paying the facilities, she said, Anthem sent checks directly to patients, some while they were still in rehab. It’s a strategy that put the providers in the tricky and tenuous position of trying to collect money — in some cases, very large sums — from the very people they were trying to help, Kantor said.
“They were trying to get better,” she said, “and Anthem was giving them every opportunity not to.”
When a patient sees an out-of-network provider, she explained, patients sign an “assignment of benefits” contract that instructs their benefit plan or its administrator to pay the provider for services rendered to the patient.
But some insurance plans have “anti-assignment” clauses that allow for payments to patients, not providers.
Anthem, the parent company of Blue Cross health plans, declined comment for this story, citing the pending litigation.
In court filings, Anthem doesn’t dispute that checks are made out to patients for various out-of-network care. But the insurance giant argued that the treatment centers don’t have legal standing to make a case in federal court under the Employee Retirement Income Security Act, known as ERISA, because patients “do not transfer any of their ERISA rights to the provider.”
“For this reason alone,” Anthem said in the filings, “each claim alleged by Plaintiffs fails as a matter of law and should be dismissed with prejudice.”
ERISA is the federal law that establishes minimum standards for most voluntarily established retirement and health plans, covering an estimated 141 million workers and beneficiaries.
Anthem also said in court filings that previous court decisions determined that “anti-assignment” provisions are legal and that the insurer is doing nothing wrong: “Indeed, courts in many other jurisdictions have held that anti-assignment clauses in ERISA plans are valid and enforceable.”

Patient: Family member got $240,000 from Anthem

Health care providers, medical professionals and attorneys familiar with this insurance practice told CNN that patients who receive money from insurers typically cannot be held criminally responsible if they never turn the cash over to their provider. But the patients can be held financially responsible.
Though many patients send the money on to the providers, they said, others might realize they’re onto a bonanza, pocketing the money and ducking and dodging every time a doctor or medical office reaches out.
Many are simply confused as to why they’re receiving money.
Candyce Ayn, a Georgia resident who recently underwent surgery with an out-of-network doctor, said she received more than $3,500 from Anthem, but she said that amount paled in comparison to the more than $240,000 sent to a family member by Anthem after a surgery a few years ago.
“The large check was surprising,” she wrote in an email. “It was more than we had paid for our house!”
Checks are still arriving for her recent surgery, she said; adding to the confusion, the checks were made out to her spouse, the main policy holder. She also said Anthem didn’t make clear or explain why the money was sent.
“Checks arrived for partial amounts, some were for amounts different than expected, and I received more checks than I had anticipated,” she said.
She paid her providers, she said, and she believes that most patients are probably like her. “Maybe there is a small percentage who think ‘Vegas, here I come!’ but I believe it is mostly confusion on the patient’s part and not at all malfeasance. Especially if there are many checks involved and they have not had the experience of going ‘out of network’ before.”
She’s thankful to have insurance, but “putting the checks in the patient’s name introduces an opportunity for things to go wrong.”
Insurance companies also make it hard for doctors, hospitals and other providers to know whether a check has been issued to a patient, refusing to disclose the information, according those familiar with the insurance practice. One Blue Cross letter, shared with CNN, told a provider that the insurer doesn’t have the “authority to disclose the financial information” and that “we are only able to instruct the provider to contact their patient.”
Sometimes, it pushes health care professionals to file suit against patients.
“I can tell you categorically that a health care provider never wants to be in a position of having to sue one of his patients for money that should’ve been paid by the patient’s insurance company,” said David King, a Nashville attorney who regularly represents providers in disputes with insurance companies. “This insurance company practice unnecessarily brings its own member into the dispute — and forces the provider to pursue the patient for the money.”
Cathryn Donaldson, a spokeswoman for the insurance advocacy group America’s Health Insurance Plans, defended the practice of insurers sending checks to patients, saying it’s because insurance companies don’t have “a contractual relationship in place with the hospital, physician or care provider.” She also took issue with the term “paying patients,” saying that “reimburses” is more appropriate.
“In the case of out-of-network care, I want to be clear that the term ‘revenge tactic’ is inaccurate and not reflective of how health insurance providers handle out-of-network costs,” Donaldson said.
She added that insurance companies are protecting patients, because out-of-network doctors, hospitals and specialists “charge whatever rates they like,” resulting in millions of patients receiving “surprise, unexpected medical bills that can often break the bank.”
NYU’s Caplan found the idea of sending money to patients ludicrous. “You’re going to be giving out these sums of money that a lot of people never see in a year and tell them their duty is to shift it over to the out-of-network service provider?” he said. “You can’t be serious.”
In a country where the vast majority of people live paycheck to paycheck, Caplan said, such policies would put most anyone in a moral and ethical bind, because “it’s ridden with almost irresistible temptations.”
“There’s a temptation, I suspect, to take the money and run,” Caplan said. “I can certainly empathize with the temptation to not play ball. … I just think that’s a ludicrous burden to put on the individual.”
Barbara L. McAneny, president of the American Medical Association, blasted what she called insurance “bully tactics” that seek to force physicians to go “in-network” — tactics that she said have become more widespread as insurance companies have grown in size and power.
“Physicians want the ability to negotiate fairly with larger health insurers without fear of strong-arm tactics that antagonize patients,” McAneny said in a written statement to CNN.
She said many health insurers ignore “assignment of benefits” agreements between patients and physicians, deciding to send payments straight to patients.
“The reality is that insurers refuse to recognize these agreements to create a market advantage for themselves against physicians who do not participate in the insurer’s network,” McAneny said.
Kantor put it this way: “How can you run a business and stay in it if you can’t get paid?”
Kantor is representing Sovereign Health, which closed last year amid financial woes and a federal probe and after being accused of fraud by another insurance company — allegations it has disputed in a countersuit.
The case against Anthem and its Blue Cross entities has been tied up in litigation for years. Kantor recently joined the case on behalf of provider Sovereign Health, streamlined it and began focusing on the payments she said went directly to patients.
She filed a motion in late January targeting the $1.3 million she says went to patients from 2012 to 2015. She said they are waiting for a hearing on the amended complaint.
In one case, a woman from Washington state received nearly $375,000, Kantor said, and the treating facility tried for more than a year to recover the money from the patient. She said a Blue Cross entity sent more than 50 checks to the woman between August 2014 and May 2015 after she sought treatment over five months in 2014.
“We don’t know what happened to the money in this case,” Kantor said. “We just know that Sovereign, our client, didn’t get any of it.”
It’s also not clear what became of the woman, she said.
In another case, a man in New York sent his fiancée’s daughter for two months of treatment at an out-of-network facility in San Diego in late 2014, Kantor said. The man is alleged to have received more than $130,000, including one check worth $79,700.
“I don’t know about you, but seeing a check for $80,000, I think, would ring alarm bells in my head,” said Tim Rozelle, an attorney working with Kantor.

Attorney: Do employees view cash as a ‘bonus’?

Anthem lost an “anti-assignment” case in federal court last year. A Los Angeles-area hospital sued the insurance company, accusing it of “an act of retaliation” for not agreeing to the insurer’s “unreasonably low contract rates.”
The Martin Luther King Jr. Community Hospital accused the insurance giant of engaging “in this practice knowing that in many instances the patients will not forward the checks to their healthcare providers or otherwise use those funds to pay for their healthcare services.”
The hospital documented three patients from the same place of work who sought emergency care, complaining of chest pains and other ailments dozens of times. The insurance company paid those three individuals a total of about $250,000, the suit said.
During one deposition, Eric Chan, the attorney for the hospital, pressed the human resources director who helped administer the health plan for the three workers about the plan’s intent.
“The intention of the plan isn’t to enrich the employees, to give them bonuses, in addition to receiving medical care, is it?” Chan asked.
“No, it’s not,” the HR director said.
But she acknowledged that she had no idea Anthem sent money directly to employees until the lawsuit arose.
Anthem’s director of group contracts and compliance said under oath that patients get “paid directly” by Anthem if they go out-of-network “because the benefit is theirs.” By contrast, the in-network providers get reimbursed directly, the Anthem representative said in her deposition.
In a ruling against Anthem, US District Judge Otis Wright described the predicament the hospital was put in: “Plaintiff realized that these individuals had no intention of paying their hospital bills and were instead profiting from Anthem’s practice of sending checks directly to patients.
“However, Plaintiff could not turn these patients away because under both state and federal law Plaintiff is obligated to treat every individual who presents to its emergency room in good faith.”
The judge entered a final judgment in December, ordering Anthem and the other defendants to pay the hospital more than $400,000. Anthem has appealed the decision.
Last year, the hospital agreed to go in-network with Anthem — a sign, critics said, that the insurance giant’s overall strategy worked.

Threatened with arrest, patient sends money to provider

Sam Fenderson, a surgical assistant in the Atlanta area, said Anthem’s tactics have very real consequences for providers like him.
He said that about $147,000 owed for his services over the past three years was sent to patients, and it’s been draining trying to recover the funds. “That was really frustrating, because the payment was there,” he said. “It was just a matter of the patient sending the payment on to me.”
He said he’s had to go to the extraordinary measure of suing 17 patients to try to get the money. He said four people declared bankruptcy, meaning he couldn’t try to recoup that money. Some of the other cases are still in small-claims court.
While most counties view the issue as a civil matter, Fenderson said, he’s found one county in Georgia that considers it a crime when patients keep the cash. Newton County considers it “theft by conversion” felony for amounts over $1,000; prosecutors said they’ve charged two people in the county.
Get CNN Health’s weekly newsletter

Sign up here to get The Results Are In with Dr. Sanjay Gupta every Tuesday from the CNN Health team.

When his patient in that county was threatened with arrest, Fenderson said, the money was turned over rather quickly.
Suing a patient to get money, he said, is a last resort and “not the way we want to operate.” The tactic even creates tension among surgical staff: Some surgeons get angry if you sue patients, Fenderson said, because they still need to see the patients for followups.
But if you don’t act, he said, “you’re working for free, essentially.”
He said the issue seems to be more common now than just a few years ago. “This is not something that’s just happening to me,” he said. “Hundreds of people I work with are going through the same thing.”
Kantor said she hopes her case shakes up the system.
“We’re going to have to change what Anthem does,” she said.

FDA warns Canadian company about distributing drugs in US

FDA warns Canadian company about distributing drugs in US

https://www.local10.com/health/fda-warns-canadian-company-about-distributing-drugs-in-us

The US Food and Drug Administration has issued a warning letter to the Canadian company CanaRx for playing a role in “the introduction of unapproved new drugs and misbranded drugs” to the United States, according to the letter.

“These drugs are potentially dangerous to U.S. consumers,” the FDA said in a news release Thursday.

An unapproved new drug has not been approved for use by the FDA. A misbranded drug fails to bear either adequate directions for its intended use or adequate warnings relating to its use.

CanaRx helps residents of the United States purchase medications from pharmacies in Canada, Australia and the United Kingdom, according to its website. Hundreds of the most commonly prescribed brand-name drugs are included in the CanaRx program, according to its website.

Joseph Morris, counsel for CanaRx Services, said in a statement Friday that the FDA’s description of the CanaRx business model is incorrect and that the company should be seen as an ally of the agency’s in the fight for patient safety.

“The CanaRx program does not involve new, experimental, unapproved or misbranded medications. Rather, CanaRx works for individual American patients who wish to exercise their rights of personal importation, as permitted by law and by the FDA’s own handbooks. CanaRx facilitates foreign physicians rewriting of the employee’s valid U.S. prescription, and then supplies the employee with approved versions of FDA-approved drugs that have been sourced from Canada, the United Kingdom or Australia where they have undergone review from those countries’ drug regulatory systems,” the statement says.

“Every prescription that is dispensed through a CanaRx program is dispensed directly to the patient from a licensed, regulated, brick-and-mortar pharmacy in Canada, the United Kingdom, or Australia, and the patient can be sure that the medicine she receives is the medicine the doctor ordered,” it says. “CanaRx believes that the FDA is trying to prevent Americans from being injured by unregulated suppliers of counterfeit and other dangerous substances. CanaRx agrees with the FDA’s goals.”

Some of the drugs received through the program treat hepatitis, cancer or HIV. The FDA letter warns that those are serious medical conditions and that side effects of drugs that may have been recalled, but still obtained through CanaRx, could be life-threatening.

The letter, sent Tuesday, also warns that certain drugs distributed by CanaRx may have different dosage strengths or trade names or be manufactured by different companies from versions of the drug that are FDA-approved and available in the United States.

“Such differences can cause patient confusion and lead to medication errors,” according to the letter, which includes a list of more than 150 websites affiliated with CanaRx.

The warning letter was sent after a “lengthy review” of the drug distributor’s practices, the FDA said.

“When a consumer goes online to buy medicines purportedly from Canada, they may get a medicine sourced from elsewhere that could be counterfeit, expired or misbranded. While operations or illegal online pharmacies may state on their websites that its medicines are coming from Canada, the United Kingdom, Australia, etc., this is not necessarily always the case,” Commissioner Dr. Scott Gottlieb said in the news release.

“Such operations and illegal online pharmacies take advantage of unsuspecting Americans by purporting to distribute safe and effective imported drugs, at least some of which are instead expired, mislabeled, subject to recalls or potentially counterfeit and that are provided outside of the closed American distribution system meant to protect patient safety,” Gottlieb said.

“Operations like CanaRx use their names to imply that patients are receiving medicines approved in Canada, when it’s likely that patients are receiving medicines from other countries, and which may be sub-potent, super-potent or counterfeit. Importantly, they’re also distributing drugs for which the FDA-approved versions are subject to additional safety requirements,” he said. “These risk mitigation programs are a legal requirement and are in place for important safety reasons. Sidestepping them is unacceptable and puts the safety of patients in great jeopardy.”

The warning letter calls for CanaRx to “promptly cease causing the distribution of unapproved new drugs and misbranded drugs to U.S. consumers and correct all other violations.” The letter also requests that the company respond within 10 working days with details on how such violations have been or will be corrected.

CanaRx said in its statement that it “will respond promptly, fairly and fully to the FDA.”

The Profiling System in Every State You Never Signed Up For Part TWO

www.medium.com/@heatherzamm/the-true-motivation-behind-the-opioid-crisis-profit-off-pdmps-and-profiling-private-data-theft-4b0ffb10e9d3

The True Motivation Behind the Opioid Crisis-Profit off PDMPs and Profiling, Private Data Theft

Part II of Profiling & Data Theft — Our “Clueless” Elected Officials are Filling Their Pockets at The Expense Of Patient Misery

States and their Statutes

If one stops to peruse the state laws on the books regarding PDMPs (prescription drug monitoring programs), there is an abundance of fascinating language buried in our very own state statutes.

For example, many states have what is called “Compacts” with other states.

These are statutes made in state law, usually over roadway or bridge construction, over licensure in nursing or medicine, with other states. They encompass an agreed upon number of states, have rules set governing etc…, have legal language with terms and so forth.

However, in regards to the Opioid Crisis… why would there even need to be a “Compact”?

And furthermore, why would this “Compact” be written like the one in Kentucky legislation has been?

Yes, here we are, back in Kentucky again- the land of Appriss, Inc., and their House of Rep. champion, Hal Rogers, of the “Hal Rogers PDMP programs”.

What a fascinating coincidence.

When I stumbled across this statute it was 2:30 am, and I was in the throes of a horrendous pancreatic flare.

Maybe these people will realize some will stop researching and chasing after their stupid machinations when they are not being harmed directly by them.

If I wasn’t being supposedly punished for idiotic actions of another, I would be able to sleep through a night.

I would have access to the medication appropriate for my condition, at the dose required and not have to worry about this ridiculous, evil, self serving propaganda play.

This crisis is really no more than a cleansing of America, as well as a dressed up profiteering of those in position to do so, at the expense of the seriously ill.

My sense of fury and outrage mounted as I read every sentence of the Kentucky Statute 218A.390 establishing the Prescription Monitoring Program Compact- not program. (This is a crucial difference).

Screencap from ky.gov

I encourage every single person to read it, twice, at the link provided.

If you have any doubts about what the real motivation of the opioid crisis is after reading it; read it again.

It appears that stakeholder interests have more to do with this crisis than anything else, whoever plays the game the right way will make the most money.

No patients or their privacy was considered, unless it would “embarrass’ a member.


Government Reveals the Lie

When HR 6, the expansive “Opioid Bill”, the Support for Patients and Communities Act, was signed by Pres. Trump on October 24, 2018, few people actually knew its entire contents.

Few realized it actually underfunded addiction treatment, yet again.

It put into place strict guidelines for treatment and how it was to be carried out.

It granted extension of the “bupe” waiver and more freedoms for the drug Suboxone to be used in substance abuse treatment for Medicaid patients, a huge win for the pharmaceutical company Indivior.

As of this writing, there is still no generic for Suboxone (bupe).

It also expanded funding for PDMP (Prescription Drug Monitoring Program) databases.

A very few people understood that last bit.


Appriss Has Been Played

With the passing of HR 6, the company Appriss, Inc., began to feel a little concerned.

This little company, based in Louisville, KY, has enjoyed a secretive monopoly on PDMP algorithm programs utilized in every state system since their inceptions into the state systems.

Beginning in mid 1990’s with the Clinton White House, but helped along by the first Bush White House, with their encouragement of EHRs.

In the first of hundreds of non coincidental coincidences, push turned into hard shove right after President Clinton signed HIPAA into law.

HIPAA being the smoke and mirrors law that pretends to protect patient privacy.

At the rate of a whopping average of 2 whole convictions per year out of 350 million Americans.

Either the American people are extremely respectful of each other’s privacy in regards to medical information or no one is enforcing HIPAA law in any real way.

As much as I would like to believe the former, the truth is the latter.

No doubt Appriss is helped along by their behind the scenes relationship with Representative Hal Rogers, a House of Representatives official from their state of KY, the “Prince of Pork”, who just so happens to be the face man for their National PDMP grant system.

Did someone say coincidence?

His ‘Hal Rogers’ PDMP grants have been the sole reason most states were even able to implement a PDMP database to enroll patients in the first place.

Now… well… the government is moving in. They are going to fund things.

Rep. Rogers would not be able to wield the power he once did… if this were to come to pass.

What to do?

Appriss Inc., executives also heard whispers that D.C. was considering making the PDMP a utility.

With the push toward a National PDMP and the certainty it will happen within the next decade, the government focus is now shifting toward whether or not the PDMP should be a public utility.

Still not a peep out of a single government official about privacy, patient consent, if PDMPs even actually work (not one study has shown a definitive yes on this), or if we need a National PDMP.

The CDC isn’t even able to say they work in stopping addiction and overdose.

Likely due to the fact PDMPs track the wrong people and wrong drugs.

A National PDMP utility would spell disaster for Appriss, Inc.

The huge checks would come to an end.

On the verge of receiving the Marconi treatment from the government, it seems.

Appriss, Inc. is worried they will become a white elephant if the government takes over the PDMP.

The company has launched a media campaign to highlight themselves, because, in reality, they do have a strict monopoly on this trade in America.

I read a fascinating analysis of this from a anon hospital insider blog, though the post itself was written by David Finney, a partner at Leap Orbit- a healthcare consulting firm in Maryland.

He writes:

“Appriss has done what monopolists do, bidding up contract prices and seeking to monetize every aspect of the data it controls. Given the commitment by states and the federal government to “do whatever it takes” to address the opioid epidemic — including supporting PDMPs with ever-increasing grant funds — PDMP administrators may grumble, but otherwise few people have stopped and taken much notice.”…

The article speaks of a National PDMP and then goes on to point out:

“By all indications, the federal omnibus spending bill and subsequent signals from federal officials and lobbyists seem poised to deliver on this new model. Not surprisingly, Appriss is worried. In recent weeks, it has launched a marketing campaign of its own to highlight the benefits of the current state-based approach to PDMPs and the interstate gateway it developed in collaboration with the National Association of Boards of Pharmacy….”

That has to sting.

This is my take on this.

Basically, the government is giving Appriss the middle finger and a good doggie pat on the head.

Appriss Inc., will be another in a long line who has been played by our dear government, developed a program, only to have it stolen and used with no recourse.

I can’t lie and say it isn’t personally satisfying to see Appriss being treated… despicably…(like a patient)… even though it underlines the treachery of our government in spades.

I will waste no more time reflecting on Appriss’s potential loss here.

When you deal in deceit- you will have it dealt to you in the future.

When you get too greedy- it never works out.

Since the others in the game, Brandeis and Yale, have day jobs, it shouldn’t hit them too hard.

Besides this site and a few other knowledgeable people, no one has said much about their connections to the PDMPs or the Opioid Crisis at all.

They haven’t been connected in the public eye.

Furthermore, the Kentucky Compact will be a moot point if a national PDMP is created.

Bye bye to that huge money generator for all the states involved, and stakeholders- of which I am certain Appriss, Inc., is the biggest one.

Of course, the yearly reports that are required by the statute written in Kentucky law are no where to be found.

There is no public list of the members or stakeholders involved in the Kentucky Prescription Monitoring Program Compact or any reports existing for review.


The Right to Know

Do we, as the patients who exist as members of the very lists involved in these databases, have a right to know who is viewing our protected, sensitive patient information?

What about informed consent?

Who asked us?

Is it right that our information is being traded to other states and stakeholders and profited off of — all without our informed consent?

Make no mistake- this has gone on for years. The Compact was created in 2012.

I wonder how much money has been made off this information in seven years already.

What will become of all the algorithm programs tailored to sell to all the states?

Does the average American understand what has happened in this power play around the Opioid Crisis?

The insurers have copycat algorithm programs now.

Appriss, Inc., has opened Pandora’s box.

There are algorithm programs to tell your physician you need to lose weight, based on your BMI- a flawed system that has no clue of your bone density or muscle mass.

A bodybuilder will be flagged for obesity even with a body fat of 8%, if their weight to height ratio is too high.

There is NO INPUT mechanism on these programs.

This is what happens when you allow computers to practice medicine- and allow the companies to use them without disclosing the fields they use for inputs.


It Takes One

In the patient community, we have tried for years to find just one.

One politician to stand up for us. One lawyer.

We have been unsuccessful.

Isn’t that astonishing?

No one is willing to stand up for patients being harmed by legislation in this opioid hysteria madness in a court of law.

It defies logic.

No one is willing to say in a court of law that privacy is being breached and invaded by these programs.

They are all too afraid.

That, more than anything, should speak to the American public.

Who is in charge? Are we?

The ACLU National has repeatedly turned down requests to represent patients, to include cancer patients, being denied compassionate pain care.

Why?

Yet, they will represent all groups of others being denied medications they require for health.

Why?

We have reams of documents, proofs, laws, contradictions, and evidence already gathered to ease the process.

For example, Robert D. Rose Jr. has attempted for years to get someone to assist him in his battle.

Doesn’t matter.

No one in a position of importance will defend a single patient who is suffering.

That should make any American pause, make any American question who really is in charge of this country.

No one will care when you are suffering and in need of help, except other people who are also suffering and in need of help.

The agencies charged with helping those who are disabled, suffering, and in need of help will let you know how they cannot help you.

You will be gaslighted to death, told to accept your lot, look on the bright side, and be mindful.

Oh, and here is a list of places who offer services.

A list of the cottage industry’s finest that sprung up around the “Opioid Crisis”.


Line the Pockets of Crony Capitalists

  • In this district, a politician’s BFF has a company that manufactures drug testing kits.

How interesting that he introduces a bill requiring that every patient be drug tested before they ever receive an opioid prescription? No exception.

And they award the contract for the state to his buddies firm.

  • In this district, a woman owns a share in yoga franchises.

Patients in this medical network are highly pressured to attend yoga before they receive an opioid prescription, and they have to go to this place, contracted by the medical network. If it doesn’t work, they are shamed heavily.

  • This politician has invested heavily in CBD.

Patients are pressured heavily to try CBD, and refused an opioid prescription. His CDB is the only kind in the area.

A politician with pain psychology.

A politician with mindfulness.

A politician with acupuncture.

Do you understand?

This is all true, how the politics has become around the opioid crisis and state legislation. The sharks moved in and have been having a field day.

A drug screen, which costs under $50 over the counter at Rite Aid, now costs upwards of $500 at a doctor’s office visit and is rarely covered by insurance.

An out of pocket cost to a patient who can ill afford it and who should not have to bear the humiliation of having one in the first place.

That patient did nothing to deserve a drug screen. It is a waste of money, period.


Join Together

When will the American public speak out for the patients who are suffering beside them?

Those of us who are fighting for ALL of us, not just ourselves.

We are fighting so that all of us can be treated with dignity and compassion.

If we don’t fight together, it will soon be too late to do anything at all.

We must force consent to be obtained for all patients to be entered into any PDMP or state tracking system- to include all the Appriss Inc., add on programs.

We must also push our politicians to fight for transparency in the algorithms used in all healthcare system programs.

Why so secretive? Competition is a great excuse to use for being discriminatory.

Is it because of racist and sexist field inputs?

Religious profiling?

We don’t know.

Until we require transparency in the algorithms, we won’t know.

Until we compel the statutes to be actually adhered to, we won’t even know what they have done the last 7 years with the patient information they collected in the PMDC- as the statute said they were to annually report.

Where are the reports?

Until America comes together and demands transparency, we will remain in the dark, allowing injustice and harm to happen to those who have done nothing wrong.

The only crime in America where you have zero, and I do mean zero, recourse…

Where no one, NOT ONE, will stand for you…

Is the crime of having the misfortune to fall ill with a incurable painful disease.


Thank you for reading!

This is Part II in a groundbreaking series on the algorithm data science and lack of informed consent surrounding the opioid crisis in 2019 America.

Please check back for coverage on this groundbreaking, vital issue!

The Profiling System in Every State You Never Signed Up For Part ONE

www.medium.com/@heatherzamm/the-profiling-system-in-every-state-you-never-signed-up-for-d2f6a886865a

Black Mirror’s “Nosedive” is already happening — the problem lies in murky consent.

Last year, I found out that I had a rare, incurable disorder.

I also found out my government was paying a privately owned company to profile and assign me a “score”.


I don’t know which news was more upsetting.

I wasn’t allowed to know my score or even how it was derived.

What is this “score”?

It is an addiction/overdose risk assessment score, assigned by an algorithm developed by Appriss, Inc., in Louisville, Kentucky.

It assessed a few values entered into data fields, then ran them through its weighted algorithm, and PRESTO!

It spits out a score just for me.

I have a science background.

I am reasonably intelligent.

I didn’t like this.

I began to dig.

Saving Us From Ourselves

Appriss, Inc., began their quest for data mining domination in the middle of the 1990s by the development of the VINE system.

VINE is a victim notification system that alerts the victims of a crime when the perp is released from jail/prison.

Reviews of this system by its users have been mixed at best. The VINE app on iPhone, for example, which is a preferred notification system for most victims, currently sits at a 1.9-star rating on the iTunes Store, with review after review of horrified, scared victim stating they were not informed.


iTunes Store Screencap 1/22/19

A software and data company has 3 apps on iTunes — 1 with no reviews, 2 with 1.9-star reviews and very angry customers because the developers appear to have abandoned any updates for over a year.


Appriss, Inc., has spent the better part of the last twenty years developing and perfecting their algorithms around schedule prescribed medications, PDMPs (prescription drug monitoring programs), and a specialized PDMP in house profiling project they ultimately named NarxCare.

This is far more lucrative to current management than the altruistic vision of the founder.

Appriss has also been responsible for the program that tracks every person who plunks down their driver’s license for Sudafed from behind the counter, the program Methcheck.

A spectacular failed attempt at slowing methamphetamine abuse by the government.

Failed because between the years 2011–2016 methamphetamine overdose deaths in the United States have more than tripled in number, according to the CDC.

A failure doesn’t get illustrated quite so resoundingly very often.

Yet, they still continue their course of stubbornly throttling prescribed opioid medication to the patients who aren’t abusing it in the first place.

Of course, this is all framed “for the best interest of public health”.

Does anyone else cringe when a public official mouths the words “best interest of public health”?

Every time those words exit a politician’s mouth, you can be certain a civil rights violation will be on its heels.

To wit, “the public” is left in the dark regarding these plots, never asked their input, and, most importantly, never asked for informed consent.

Little is known about the data fields Appriss actually inputs.

The algorithms are proprietary.

Furthermore, the state statutes written around PMP/PDMPs have this little nugget hidden inside:

“Program to contract with vendors/3rd parties for the purpose of “obtaining technical assistance in the design, implementation, operation, and maintenance” of the system. “


Questions addressed to the state agencies /reps regarding them are ignored.

What I have been able to ascertain independently is troubling.

Appriss has introduced a number of “add-on” packages to the basic PDMP that each state has in place- thanks to Brandeis University.

The Brandeis proprietary PDMPassist has been the author of the state PDMP metrics and algorithms for each state PDMP program.

Congressman Hal Rogers, of Kentucky, is the PDMP ‘face man’ at a national level.

The ‘Hal Rogers’ PDMP grant program has funded many states’ programs and gotten them up and running.

The Congressman’s moniker is attached to all things PDMP for no obvious reason.

The only thing Rep. Rogers appears known for besides the PDMP programs in his name is being dubbed “the Prince of Pork” by government spending watchdog groups.

He also served as the chairman of the House Appropriations Committee for a short time.

Appriss, Inc., HQ is located in Kentucky as previously mentioned, same as Rep. Rogers.

One thing I have learned in my research throughout the bizarre turns of the opioid crisis is that there are no coincidences.


One of the add-on programs that almost all states have implemented to their PDMPs is called “PDMP AwaRxe”.

This program is nothing more than Appriss, Inc.’s, insidious NarxCare under a different name.

This is also where the “scoring” comes into play.

With NarxCare, a patient gets what is referred to as a NarxScore.

Herein the problem lies.

The PDMP, NarxCare, PDMP AwaRxe, et al., are all rudimentary algorithm programs.

They do not allow for any inputs by a physician into data fields.

This is a problem.

Why?

It’s a problem because of many factors, firstly, that patients are not told that they are being high scored or “red flagged” for innocent behavior.

Here is an example of how a patient can be pressured into rehab for a computer algorithm decided diagnosis of addiction when it is, in fact, normal behavior.

Betty is a pastor’s wife who suffers chronic pancreatitis. On Sept 1, she went to an appointment with a new pain management physician.

Her new physician wanted her to be committed for treatment for SUD based on what the computer told him and the flag it gave him regarding Betty.

When she refused to go, he called her husband and enlisted his help to try to convince Betty to go.


photo from Unsplash @cinestock

How did this happen?

The computer algorithm told her new physician that Betty was an extremely high-risk patient.

It said she was a doctor shopper who went to multiple providers and pharmacies over the past 9 months.

It recommended that she seek treatment immediately.

The physician would not listen to Betty when she attempted to explain what happened in the past 9 months.

Addicts are liars.


What did actually happen?

In January, 9 months previously, Betty had her normal pain management appointment.

Three weeks later she was in a terrible car accident (not her fault) and taken by ambulance to a local hospital.

When she was discharged, four days later, it was a Saturday afternoon, around 5 PM.

The orthopedic physician who treated her broken ankle in the hospital wrote her a prescription for pain medication after he spoke to her pain management physician and they came up with a plan.

Her husband filled the prescription at a Walmart pharmacy because their normal pharmacy was closed.

Betty had her normal pain management appointment in March. She was hospitalized at the end of March with appendicitis that had perforated her bowel.

The GI doc discharged her with a few days of pain medication on top of her pain management after consulting her pain management physician.

The prescription was filled at the hospital pharmacy before they left the hospital.

Betty had her normal pain management appointment in May.

She had an infected root canal removed in June and required extensive dental surgery along with a bone graft in her jaw.

Her oral surgeon prescribed pain medicine after consulting with her pain management physician.

Her husband filled the script for her at the Rite Aid near the dentist office because she was in terrible pain and he wanted her to have the medication for the trip home (a 2-hour drive).


Photo from Twenty20 @inamoment rights to use purchased by author

Betty had her normal pain management appointment in July.

Her physician told her he was retiring.

He gave her a few names of physicians in the area.

Betty made an appointment with the new physician for September. She had all her records forwarded there.

Betty had a flare-up of acute pancreatitis at the beginning of August.

She was hospitalized for three days, then discharged with a 4 day prescription of extra pain medicine from the hospitalist.

Her husband filled the script at the Rite Aid by the hospital because it was the only pharmacy open on Sunday.


Because Betty had five different physicians and five different pharmacies recorded within the past 9 months in her records dispensing prescribed opioids, the algorithm automatically flagged her and recommended rehab — all per the NarxCare programming.

The literature says to “have a discussion”.


From Pexels user thatguycraig

No physician in practice utilizing the NarxCare system is following any of the “recommendations” provided in any of these “guides” past the words; “cut off” or “rehab” that I have heard of, anecdotally.

After all, the entire premise of this is based on the CDC guidelines for opioid prescribing for chronic pain, a voluntary guide for new patients, not existing ones, which have never once been utilized in the way they were written — to include the premise of Narxcare in the first place!